Skip to main content
. 2021 Jul 21;22:574–581. doi: 10.1016/j.omto.2021.07.004

Table 1.

The correlations between FOXD2-AS1 and cervical cancer patients’ clinicopathological characteristics

FOXD2-AS1 p
Low (15) High (15)

Age, years 0.617
<45 13 7 6
≥45 17 8 9
Tumor size, cm 0.008
<4 11 8 3
≥4 19 7 12
FIGO stages 0.187
I/II 16 6 10
III/IV 14 9 5
Tumor differentiation 0.248
Well/moderate 18 10 8
Poor 12 5 7
Lymph node metastasis 0.173
Positive 10 4 6
Negative 20 11 9